Department of Surgery, Division of General and Hepatobiliary Surgery, G.B. Rossi University Hospital, University of Verona, Verona, Italy.
Department of Surgery, Division of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center - IRCCS, Humanitas University, Rozzano (Milan), Italy.
Eur J Surg Oncol. 2020 Sep;46(9):1727-1733. doi: 10.1016/j.ejso.2020.04.007. Epub 2020 Apr 19.
We aimed to investigate the impact of vascular resection (VR) on postoperative outcomes and survival of patients undergoing hepatectomy for intrahepatic cholangiocarcinoma (ICC).
A retrospective analysis of a multi-institutional series of 270 patients with resected ICC was carried out. Patients were divided into three groups: portal vein VR (PVR), inferior vena cava VR (CVR) and no VR (NVR). Univariate and multivariate analysis were applied to define the impact of VR on postoperative outcomes and survival.
Thirty-one patients (11.5%) underwent VR: 15 (5.6%) to PVR and 16 (5.9%) to CVR. R0 resection rates were 73.6% in NVR, 73.3% of PVR and 68.8% in CVR. The postoperative mortality rate was increased in VR groups: 2.5% in NVR, 6.7% in PVR and 12.5% in CVR. The 5-years overall survival (OS) rates progressively decreased from 38.4% in NVR, to 30.1% in CVR and to 22.2% in PVR, p = 0.030. However, multivariable analysis did not confirm an association between VR and prognosis. The following prognostic factors were identified: size ≥50 mm, patterns of distribution of hepatic nodules (single, satellites or multifocal), lymph-node metastases (N1) and R1 resections. In the VR group the 5-years OS rate in patients without lymph-node metastases undergoing R0 resection (VRR0N0) was 44.4%, while in N1 patients undergoing R1 resection was 20% (p < 0.001).
Vascular resection (PVR and CVR) is associated with higher operative risk, but seems to be justified by the good survival results, especially in patients without other negative prognostic factors (R0N0 resections).
本研究旨在探讨血管切除(VR)对接受肝切除术治疗肝内胆管细胞癌(ICC)患者术后结局和生存的影响。
对 270 例接受肝切除术治疗 ICC 的多机构系列患者进行回顾性分析。患者分为三组:门静脉 VR(PVR)、下腔静脉 VR(CVR)和无 VR(NVR)。采用单因素和多因素分析确定 VR 对术后结局和生存的影响。
31 例患者(11.5%)接受了 VR:15 例(5.6%)行 PVR,16 例(5.9%)行 CVR。NVR、PVR 和 CVR 的 R0 切除率分别为 73.6%、73.3%和 68.8%。VR 组的术后死亡率增加:NVR 组为 2.5%,PVR 组为 6.7%,CVR 组为 12.5%。5 年总生存率(OS)从 NVR 的 38.4%逐渐下降至 CVR 的 30.1%和 PVR 的 22.2%,p=0.030。然而,多变量分析并未证实 VR 与预后相关。确定的预后因素包括:肿瘤直径≥50mm、肝内结节分布模式(单发、卫星或多发)、淋巴结转移(N1)和 R1 切除。在 VR 组中,无淋巴结转移行 R0 切除(VRR0N0)患者的 5 年 OS 率为 44.4%,而 N1 患者行 R1 切除的 OS 率为 20%(p<0.001)。
血管切除(PVR 和 CVR)与较高的手术风险相关,但在没有其他负性预后因素(R0N0 切除)的患者中似乎可获得良好的生存结果。